ALNY vs SGBX · P/E 76, rev $1.29B vs rev $5.0M
Alnylam Pharmaceuticals Inc (ALNY) versus SG Blocks Inc (SGBX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
SG Blocks Inc (SGBX) is a metal fabrication company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SGBX revenue for 2024-12-31 was $5.0M. Net income was -$17.0M. Revenue was down 69.9% from 2023-12-31 to 2024-12-31. SGBX currently screens at market cap $9.3M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SGBX currently screens at market cap $9.3M.
Not investment advice. Open the ALNY and SGBX stock pages for the full models.
Not investment advice.